Silencing PCSK9 reshapes the spatiotemporal activation of STING for safe and effective cancer immunotherapy. [PDF]
Sun P +7 more
europepmc +1 more source
Computer-aided design enables repurposing of proprotein convertase subtilisin/kexin type 9 degrader from cholesterol-lowering to colon cancer therapy. [PDF]
Fan G +6 more
europepmc +1 more source
Statin administration or blocking PCSK9 alleviates airway hyperresponsiveness and lung fibrosis in high-fat diet-induced obese mice [PDF]
Lin Liang +5 more
openalex +1 more source
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9): The Multifaceted Biology, Diseases, and Pharmaceutical Interventions. [PDF]
Kuang J, Hao L, Zhang M, Yang Z.
europepmc +1 more source
Proteome-wide Mendelian randomization identifies drug targets for atrial fibrillation/flutter. [PDF]
Jia Q, Yang Y, Chen X, Hu Z.
europepmc +1 more source
Lipid management: maximising reduction of cardiac risk [PDF]
Gonna, H, Ray, KK, Webb, J
core +1 more source
A disproportionality analysis on proprotein convertase subtilisin/kexin type 9 inhibitors and hypersensitivity and anaphylaxis. [PDF]
Dermiki-Gkana F +3 more
europepmc +1 more source
Quercetin's regulation of glucose and lipid metabolism in gestational diabetes mellitus: role of the PCSK9/LDLR axis. [PDF]
Hong L, Xia S, Chen N, Wang Z, Li Z.
europepmc +1 more source
Endothelial Cell-Derived PCSK9 in Atherosclerosis: Pathophysiological Roles and Therapeutic Perspectives. [PDF]
Wang P, Wang H, Yan D, Zhang Z.
europepmc +1 more source

